Search

Your search keyword '"Sanmartí, Raimon"' showing total 672 results
Start Over Author "Sanmartí, Raimon"
672 results on '"Sanmartí, Raimon"'

1. Subsequent biologic and targeted synthetic disease modifying anti rheumatic drugs after fulfilling difficult-to-treat rheumatoid arthritis criteria: a survival analysis

Author

Novella-Navarro, Marta, Ruiz-Esquide, Virginia, López-Juanes, Natalia, Chacur, Chafik Alejandro, Monjo-Henry, Irene, Nuño, Laura, Peiteado, Diana, Villalba, Alejandro, Fernández-Fernandez, Elisa, Sanz-Jardón, María, Kafati, Mónica, Sanmartí, Raimon, Plasencia-Rodríguez, Chamaida, and Balsa, Alejandro

Published
2024
Full Text
View/download PDF

2. Seven-chain adaptive immune receptor repertoire analysis in rheumatoid arthritis reveals novel features associated with disease and clinically relevant phenotypes

Author

Aterido, Adrià, López-Lasanta, María, Blanco, Francisco, Juan-Mas, Antonio, García-Vivar, María Luz, Erra, Alba, Pérez-García, Carolina, Sánchez-Fernández, Simón Ángel, Sanmartí, Raimon, Fernández-Nebro, Antonio, Alperi-López, Mercedes, Tornero, Jesús, Ortiz, Ana María, Fernández-Cid, Carlos Marras, Palau, Núria, Pan, Wenjing, Byrne-Steele, Miranda, Starenki, Dmytro, Weber, Daniel, Rodriguez-Nunez, Ivan, Han, Jian, Myers, Richard M., Marsal, Sara, and Julià, Antonio

Published
2024
Full Text
View/download PDF

5. Rheumatologic complications of CAR-T Cell therapy. Experience of a single center

Author

Gómez-Puerta, José A, Monegal, Ana, Ponce, Andrés, Peris, Pilar, Martínez-Cibrian, Nuria, Sarmiento-Monroy, Juan Camilo, Ortiz-Maldonado, Valentin, Triguero, Ana, Fernández de Larrea, Carlos, Delgado, Julio, García-Herrera, Adriana, Albero-González, Raquel, Bosch-Amate, Xavier, Español-Rego, Marta, González, Azucena, Sanmartí, Raimon, and Juan, Manel

Published
2025
Full Text
View/download PDF

9. Retention of subcutaneous abatacept for the treatment of rheumatoid arthritis: real-world results from the ASCORE study: an international 2-year observational study

Author

Alten, Rieke, Mariette, Xavier, Flipo, René-Marc, Caporali, Roberto, Buch, Maya H., Patel, Yusuf, Marsal, Sara, Sanmartí, Raimon, Nurmohamed, Michael T., Griffiths, Hedley, Peichl, Peter, Bannert, Bettina, Chartier, Melanie, Connolly, Sean E., Lozenski, Karissa, and Rauch, Christiane

Published
2022
Full Text
View/download PDF

12. Longitudinal analysis of blood DNA methylation identifies mechanisms of response to tumor necrosis factor inhibitor therapy in rheumatoid arthritis

Author

Julià, Antonio, Gómez, Antonio, López-Lasanta, María, Blanco, Francisco, Erra, Alba, Fernández-Nebro, Antonio, Mas, Antonio Juan, Pérez-García, Carolina, Vivar, Ma Luz García, Sánchez-Fernández, Simón, Alperi-López, Mercedes, Sanmartí, Raimon, Ortiz, Ana María, Fernandez-Cid, Carlos Marras, Díaz-Torné, César, Moreno, Estefania, Li, Tianlu, Martínez-Mateu, Sergio H., Absher, Devin M., Myers, Richard M., Molina, Jesús Tornero, and Marsal, Sara

Published
2022
Full Text
View/download PDF

16. A multidisciplinary registry of patients with autoimmune and immune-mediated diseases with symptomatic COVID-19 from a single center

Author

Sarmiento-Monroy, Juan C., Espinosa, Gerard, Londoño, Maria-Carlota, Meira, Fernanda, Caballol, Berta, Llufriu, Sara, Carrasco, Josep Lluis, Moll-Udina, Aina, Quintana, Luis F., Giavedoni, Priscila, Ramírez, Julio, Inciarte-Mundo, Jose, Solana, Elisabeth, Blanco, Yolanda, Martinez-Hernandez, Eugenia, Sepúlveda, Maria, Llorenç, Victor, Prieto-González, Sergio, Espígol-Frigolé, Georgina, Milisenda, Jose C., Cid, Maria C., Mascaró, Jose M., Jr., Blanco, Isabel, Barberá, Joan Albert, Sibila, Oriol, Gratacos-Ginès, Jordi, Adán, Alfredo, Agustí, Alvaro, Sanmartí, Raimon, Panés, Julian, Cervera, Ricard, Vila, Jordi, Soriano, Alex, and Gómez-Puerta, José A.

Published
2021
Full Text
View/download PDF

18. Anti-Modified Peptide Antibodies (AMPAs) in Rheumatoid Arthritis: Study of the Diagnostic Value of Citrullinated, Homocitrullinated, and Acetylated Fibrin/Filaggrin Chimeric Peptides.

Author

Haro, Isabel, Castellanos-Moreira, Raul, Sanmartí, Raimon, and Gómara, María José

Subjects
PEPTIDES, PEPTIDOMIMETICS, FILAGGRIN, RHEUMATOID factor, BLOOD diseases
Abstract

Background/Objectives. The presence of anti-citrullinated peptide/protein antibodies (ACPAs), anti-carbamylated peptide/protein antibodies (anti-CarPs), and anti-acetylated peptide/protein antibodies (AAPAs), collectively termed as anti-modified peptide/protein antibodies (AMPAs), is a hallmark of rheumatoid arthritis. These autoantibodies play a crucial role in the complex autoimmune responses observed in patients. Understanding the interplay between them is essential for early diagnosis and effective management of the disease. Methods. In this work, we investigate IgG, IgM, and IgA levels of ACPAs, anti-CarPs, and AAPAs in two cohorts: patients with established RA disease and healthy blood donors, using a unique peptide antigenic backbone. Results. Our results showed that antibody levels of anti-citrullinated peptide (CFFCP) and anti-homocitrullinated peptide (CFFHP) were significantly higher in RA patients compared to healthy blood donors in the three isotypes analyzed, IgG, IgA, and IgM. Fine specificities were more frequent when using the CFFCP antigen. Regarding the reactivity to the acetyl-lysine modified peptide (CFFAP), the correlation between IgA and IgG/IgM was very weak. CCFAP was highly specific for isotypes IgG and IgA, but its sensitivity was low for both isotypes. Anti-CarP and AAPA are significant in the context of RA, particularly concerning their IgA isotypes. Conclusions. Their inclusion in diagnostics assessments for RA, especially for anti-citrulline negative cases, presents a potential advance in the field; however, they do not replace yet traditional markers like rheumatoid factor (RF) and ACPAs. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

19. The So-Called Pre-Clinical Rheumatoid Arthritis: Doubts, Challenges, and Opportunities.

Author

Sanmartí, Raimon, Frade-Sosa, Beatriz, and Ponce, Andres

Subjects
*JOINT diseases, *JOINTS (Anatomy), *JOINT stiffness, *SYMPTOMS, *DISEASE risk factors, *SYNOVITIS, *JOINT pain
Abstract

The editorial in the Journal of Clinical Medicine discusses a case of a 46-year-old female scientist with symptoms suggestive of pre-rheumatoid arthritis. The presence of anti-CCP antibodies indicates a high risk of progression to rheumatoid arthritis. The article explores the challenges in managing individuals at this pre-arthritis stage, including uncertainties about the appropriate treatment and the benefits of antirheumatic drugs. It also highlights ongoing research efforts to better understand the immunological mechanisms driving the progression from pre-RA to clinical RA, with the goal of optimizing patient management and potentially preventing the development of persistent and destructive polyarthritis. [Extracted from the article]

Published
2024
Full Text
View/download PDF

20. Efficacy of baricitinib in patients with moderate-to-severe rheumatoid arthritis up to 6.5 years of treatment: results of a long-term study.

Author

Caporali, Roberto, Taylor, Peter C, Aletaha, Daniel, Sanmartí, Raimon, Takeuchi, Tsutomu, Mo, Daojun, Haladyj, Ewa, Bello, Natalia, Zaremba-Pechmann, Liliana, Fang, Ying, and Dougados, Maxime

Subjects
RESEARCH funding, RHEUMATOID arthritis, METHOTREXATE, ANTIRHEUMATIC agents, SEVERITY of illness index, TREATMENT duration, DESCRIPTIVE statistics, JANUS kinases, DOSE-effect relationship in pharmacology, DRUG efficacy, NEUROTRANSMITTER uptake inhibitors, EVALUATION
Abstract

Objectives To evaluate the long-term efficacy of once-daily baricitinib 4 mg or 2 mg in patients with active rheumatoid arthritis who had inadequate response (IR) to MTX, csDMARDs or bDMARDs. Methods Data from three completed phase III studies—RA-BEAM (MTX-IR), RA-BUILD (csDMARD-IR) and RA-BEACON (bDMARD-IR)—and one completed long-term extension study (RA-BEYOND) were analysed up to 6.5 years [340 weeks (RA-BEAM) and 336 weeks (RA-BUILD and RA-BEACON)]. Low disease activity (LDA) [Simplified Disease Activity Index (SDAI) ≤11], clinical remission (SDAI ≤3.3) and physical function [Health Assessment Questionnaire Disability Index (HAQ-DI) ≤0.5] were the main outcomes assessed. Completer and non-responder imputation (NRI) analyses were conducted on each population. Results At week 340 or 336, LDA was achieved in 37%/83% of MTX-IR, 35%/83% of csDMARD-IR and 23%/73% of bDMARD-IR patients treated with baricitinib 4 mg, assessed by NRI/completer analyses, respectively. Remission was achieved in 20%/40% of MTX-IR, 13%/32% of csDMARD-IR and 9%/30% of bDMARD-IR patients treated with baricitinib 4 mg, assessed by NRI/completer analyses, respectively. HAQ-DI ≤0.5 was reached in 31%/51% of MTX-IR, 25%/46% of csDMARD-IR and 24%/38% of bDMARD-IR patients treated with baricitinib 4 mg, assessed by NRI/completer analyses, respectively. Conclusion Treatment with baricitinib 4 mg or 2 mg demonstrated efficacy up to 6.5 years with maintained LDA/remission results across SDAI, CDAI and DAS28-hsCRP consistent with previously reported data, and was well tolerated. Trial registration United States National Library of Medicine clinical trials database www.clinicaltrials.gov ; RA-BEYOND; NCT01885078. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

21. Novel Chimeric Peptides Based on the Enolase Peptide Antigen (CEP-1) Bearing Three Post-Translational Modifications (Citrullination, Homocitrullination and Acetylation) for Determining the Diagnosis and Severity of Rheumatoid Arthritis.

Author

Gómara, María José, Sarmiento-Monroy, Juan C., Castellanos-Moreira, Raul, Gómez-Puerta, José A, Sanmartí, Raimon, and Haro, Isabel

Subjects
PEPTIDES, PEPTIDOMIMETICS, FILAGGRIN, RHEUMATOID arthritis diagnosis, JOINTS (Anatomy)
Abstract

With the aim of improving the uncertainties associated with the correct diagnosis of seronegative rheumatoid arthritis (RA) and identifying those at risk of developing interstitial lung disease (ILD), we have designed new peptide antigens bearing three post-translational modifications (PTMs) (citrulline, homocitrulline and acetyl-lysine) related to RA that could complement existing tests based on anti-citrullinated peptide/protein antibodies (ACPAs). Several chimeric peptides were synthesized and comparatively tested as antigens in ELISAs with two cohorts of sera: 178 RAs and 110 healthy blood donors. The results indicated that although chimeric peptides containing all three PTMs and vimentin and enolase domains do not significantly outperform existing ACPA tests in terms of sensitivity and specificity, they show potential to complement current assays, especially when detecting antibodies in some seronegative patients. Furthermore, the presence of these autoantibodies significantly identified patients with RA and ILD. We can conclude that the identification of specific autoantibody profiles using synthetic antigens containing peptide domains derived from proteins present in the human joint could help in the early detection of the risk of ILD in patients with RA and be useful for adapting follow-up strategies and guiding decisions during treatment. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

24. Efficacy and safety of combined therapy with synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: Systematic literature review

Author

Calvo Alén, Jaime, Pérez, Trinidad, Romero Yuste, Susana, Ferraz-Amaro, Iván, Alegre Sancho, Juan José, Pinto Tasende, José Antonio, Maceiras Pan, Francisco, Quevedo, Juan Carlos, Hernández-Hernández, M. Vanesa, Hidalgo Calleja, Cristina, San Martín Álvarez, Alejandro, Tevar Sánchez, María Isabel, and Sanmartí, Raimon

Published
2020
Full Text
View/download PDF

26. Eficacia y seguridad de la terapia combinada con fármacos modificadores de la enfermedad sintéticos en la artritis reumatoide: revisión sistemática de la literatura

Author

Calvo Alén, Jaime, Pérez, Trinidad, Romero Yuste, Susana, Ferraz-Amaro, Iván, Alegre Sancho, Juan José, Pinto Tasende, José Antonio, Maceiras Pan, Francisco, Quevedo, Juan Carlos, Hernández-Hernández, M. Vanesa, Hidalgo Calleja, Cristina, San Martín Álvarez, Alejandro, Sánchez, María Isabel Tevar, and Sanmartí, Raimon

Published
2020
Full Text
View/download PDF

34. Interactions between rheumatoid arthritis antibodies are associated with the response to anti-tumor necrosis factor therapy

Author

Julià, Antonio, López-Lasanta, María, Blanco, Francisco, Gómez, Antonio, Haro, Isabel, Mas, Antonio Juan, Erra, Alba, Vivar, Ma Luz García, Monfort, Jordi, Sánchez-Fernández, Simón, González, Isidoro, Alperi, Mercedes, Castellanos-Moreira, Raúl, Fernández-Nebro, Antonio, Díaz-Torné, César, Palau, Núria, Lastra, Raquel, Lladós, Jordi, Sanmartí, Raimon, and Marsal, Sara

Published
2021
Full Text
View/download PDF

35. A Composite Indicator to Assess the Quality of Care in the Management of Patients With Rheumatoid Arthritis in Outpatient Rheumatology Clinics

Author

Martín-Martínez, María Auxiliadora, Andreu-Sanchez, Jose Luis, Sanchez-Alonso, Fernando, Corominas, Hector, Perez-Venegas, Jose Javier, Roman-Ivorra, Jose Andres, Alperi, Mercedes, Blanco-Alonso, Ricardo, Caliz, Rafael, Chamizo-Carmona, Eugenio, Graña-Gil, Jenaro, Hernández, Blanca, Marras, Carlos, Mazzucchelli, Ramon, Medina Luezas, Julio Antonio, Naranjo-Hernández, Antonio, Ortiz, Ana, Roselló, Rosa, Sanchez-Nievas, Ginés, Sanmartí, Raimon, and Vela-Casasempere, Paloma

Published
2019
Full Text
View/download PDF

36. Indicador compuesto para evaluar la calidad asistencial en el manejo de los pacientes con artritis reumatoide en las consultas externas de Reumatología

Author

Martín-Martínez, María Auxiliadora, Andreu-Sanchez, Jose Luis, Sanchez-Alonso, Fernando, Corominas, Hector, Perez-Venegas, Jose Javier, Roman-Ivorra, Jose Andres, Alperi, Mercedes, Blanco-Alonso, Ricardo, Caliz, Rafael, Chamizo-Carmona, Eugenio, Graña-Gil, Jenaro, Hernández, Blanca, Marras, Carlos, Mazzucchelli, Ramon, Medina Luezas, Julio Antonio, Naranjo-Hernández, Antonio, Ortiz, Ana, Roselló, Rosa, Sanchez-Nievas, Ginés, Sanmartí, Raimon, and Vela-Casasempere, Paloma

Published
2019
Full Text
View/download PDF

37. Prevalence of Comorbidities in Rheumatoid Arthritis and Evaluation of Their Monitoring in Clinical Practice: The Spanish Cohort of the COMORA Study

Author

Balsa, Alejandro, Lojo-Oliveira, Leticia, Alperi-López, Mercedes, García-Manrique, María, Ordóñez-Cañizares, Carmen, Pérez, Lorena, Ruiz-Esquide, Virginia, Corrales, Alfonso, Narváez, Javier, Rey-Rey, José, Rodríguez-Lozano, Carlos, Ojeda, Soledad, Muñoz-Fernández, Santiago, Nolla, Joan M., García-Torrón, José, Gamero, Fernando, García-Vicuña, Rosario, Hernández-Cruz, Blanca, Campos, José, Rosas, José, García-Llorente, José Francisco, Gómez-Centeno, Antonio, Cáliz, Rafael, Sanmartí, Raimon, Bermúdez, Alberto, Abasolo-Alcázar, Lydia, Fernández-Nebro, Antonio, Rodríguez-Rodríguez, Luis, Marras, Carlos, González-Gay, Miguel Ángel, Hmamouchi, Ihsane, and Martín-Mola, Emilio

Published
2019
Full Text
View/download PDF

39. Axial Disease in Psoriatic Arthritis: A Challenging Domain in Clinical Practice.

Author

Alascio, Lucía, Azuaga-Piñango, Ana Belén, Frade-Sosa, Beatriz, Sarmiento-Monroy, Juan C., Ponce, Andrés, Farietta, Sandra, Gómez-Puerta, Jose A., Sanmartí, Raimon, Cañete, Juan D., and Ramírez, Julio

Subjects
ANKYLOSING spondylitis, SPONDYLOARTHROPATHIES, INTERLEUKIN-23, BIOTHERAPY, INTERLEUKIN-17
Abstract

Psoriatic arthritis (PsA) is a chronic inflammatory condition affecting about one-third of individuals with psoriasis. Defining axial involvement in PsA (axPsA) remains debated. While rheumatologists guide clinical practice, consensus on axPsA is still lacking. This paper explores historical and upcoming definitions from the Axial Involvement in Psoriatic Arthritis (AXIS) study, which aims to establish a validated axPsA definition. Epidemiological data reveal diverse axPsA prevalence rates, emphasizing its complex relationship with peripheral arthritis and enthesitis. Unique genetic, clinical, and radiological features differentiate axPsA from ankylosing spondylitis (AS), necessitating refined classification criteria. The recommendations from the Assessment of Spondylarthritis international Society (ASAS) provide valuable guidance due to the limited direct evidence. Emerging therapies, including interleukin-23 (IL-23) inhibitors or Janus kinase (JAK) inhibitors, are under investigation for axPsA. Currently, secukinumab, an interleukin-17 (IL-17) inhibitor, is an evidence-based option for axPsA management. However, given the variability in individual patient responses and disease manifestations, personalized, evidence-based treatment approaches remain essential for optimizing patient outcomes. In the final section, two real-life cases illustrate the challenges in managing axPsA, emphasizing the importance of tailored therapies. Achieving precision in defining axPsA remains a formidable task, making detailed criteria essential for effective strategies and improving patient outcomes. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

42. Recommendations for the Use of Parenteral Methotrexate in Rheumatic Diseases

Author

Tornero Molina, Jesús, Calvo Alen, Jaime, Ballina, Javier, Belmonte, María Ángeles, Blanco, Francisco J., Caracuel, Miguel Ángel, Carbonell, Jordi, Corominas, Héctor, Chamizo, Eugenio, Hidalgo, Cristina, Román Ivorra, José, Marenco, José Luis, Moreno Muelas, José Vicente, Muñoz-Fernández, Santiago, Nolla, Joan M., Pérez, Trinidad, Sanmarti, Raimon, Trenor, Pilar, Urrego, Claudia, Vidal, Javier, and Gomez de Salazar, José Rosas

Published
2018
Full Text
View/download PDF

43. Recomendaciones sobre el uso de metrotexato parenteral en enfermedades reumáticas

Author

Tornero Molina, Jesús, Calvo Alen, Jaime, Ballina, Javier, Belmonte, María Ángeles, Blanco, Francisco J., Caracuel, Miguel Ángel, Carbonell, Jordi, Corominas, Héctor, Chamizo, Eugenio, Hidalgo, Cristina, Ivorra, José Román, Marenco, José Luis, Moreno Muelas, José Vicente, Muñoz-Fernández, Santiago, Nolla, Joan M., Pérez, Trinidad, Sanmarti, Raimon, Trenor, Pilar, Urrego, Claudia, Vidal, Javier, and Rosas Gomez de Salazar, José

Published
2018
Full Text
View/download PDF

44. Measuring inflammation in rheumatoid arthritis with a new clinical and ultrasound index: development and initial validation

Author

de Agustín, Juan José, Erra, Alba, Ponce, Andrés, Moragues, Carmen, Díaz-Torné, Cesar, Reina, Delia, Moreno, Estefanía, Ramírez, Julio, Mateo, Lourdes, Pujol Busquets, Manel, Moya, Patricia, Santo-Panero, Pilar, Ros-Expósito, Sergi, Narváez, Javier, Sanmartí, Raimon, García de Yébenes, Mª Jesús, and Carmona, Loreto

Published
2019
Full Text
View/download PDF

47. REDOSER project: optimising biological therapy dose for rheumatoid arthritis and spondyloarthritis patients

Author

González-Álvaro, Isidoro, Blasco, Antonio J., Lázaro, Pablo, Sánchez-Piedra, Carlos, Almodovar, Raquel, Bachiller-Corral, Javier, Balsa, Alejandro, Caliz, Rafael, Candelas, Gloria, Fernández-Carballido, Cristina, García-Aparicio, Angel, García-Magallón, Blanca, García-Vicuña, Rosario, Gómez-Centeno, Antonio, Ortiz, Ana M., Sanmartí, Raimon, Sanz, Jesús, and Tejera, Beatriz

Published
2017
Full Text
View/download PDF

48. Lipoprotein(a) concentrations in rheumatoid arthritis on biologic therapy: Results from the CARdiovascular in rheuMAtology study project

Author

de Rábago, Eugenia Gonzalez, Blanco Morales, Elena Alonso, Fernández López, J. Carlos, Villar, Natividad Oreiro, Sandoval, Antonio Atanes, Blanco García, Francisco J., De Miquel, Cayetano Alegre, González Fernández, María J., Codina, Ramón Huguet, Yoldi, Beatriz, Ramentol, Mercedes, Ávila, Gabriela, Barril, Sara Marsal, Steiner, Martina, Muñoz, Santiago, Gamero, Fernando, Torón, José García, Moreno Gil, María P., Mas, Antonio J., Espiño, Pilar, Ros, Inmaculada, Ibañez, Mónica, Murillo, Claudia, Piqueras, José A., Sanmartí, Raimon, Berman, Horacio, Cabrera, Sonia, Ruiz, Virginia, Patón, Oscar Fontseré, Gutiérrez, Benjamín Fernández, Abasolo, Lydia, Fábregas, María D., Nolla, Joan M., Arias, Miriam García, García Vadillo, Jesús A., de Vicuña, Rosario García, Nebro, Antonio Fernández, Belmonte López, Maria Angeles, Ureña, Inmaculada, Irigoyen, María V., Cagigal, Virginia Coret, González, Ruth López, Garrido, Daniel Pielfort, Alvarez, Juana Sampedro, García Aparicio, Ángel María, Gómez, Rebeca Belmonte, Bautista, Pastora Granados, Sanz, Azucena Hernández, Sánchez González, Carmen O., Bachiller, Javier, Zea, Antonio, Manero, Francisco J., Zorzo, Fernando Jimenez, Ubeda, Eugenio Giménez, Gracía, Jesús Marzo, Audera, Chesús Beltrán, Medrano, Marta, Pecondón, Ángela, Erausquin, Celia, Ojeda, Soledad, Quevedo, Juan Carlos, Francisco, Félix, Lozano, Carlos Rodríguez, Herráez, Jesús Babío, López Longo, Francisco J., Gerona, Delia, Fernández, Carlos González, Carreño, Luis, Monteagudo, Indalecio, del Pino, Javier, Sánchez González, María Dolores, Corrales, Alfonso, Peiró, María Enriqueta, Senabre, José M., Rosas, José C., Rotés, Isabel, Moreno, Estefanía, Erra, Alba, Grado, Dolors, Calvo, Javier, Rueda, Amalia, Möller, Ingrid, Rodríguez, Isabel, Barbadillo, Carmen, Raya, Enrique, Morales, Pilar, Nieto, Ana, Jiménez, Inmaculada, magro, Cesar, Escribano, Ana Ruibal, Expósito, Sergio Ros, Nievas, Ginés Sánchez, Navarro, Enrique Júdez, Fernández, Manuela Sianes, García Morales, María Ángeles, Bastero, Isabel Labiano, Consuegra, Gloria García, Palmou, Natalia, Pardo, Silvia Martínez, Pujol, Manel, Alonso, Elena Riera, Salvador, Georgina, Alvarez, Beatriz González, Cantabrana, Alberto, Bustabad, Sagrario, Delgado, Esmeralda, Muñoz, Alejandro, Montero, Sergio Rodríguez, Jiménez, Luis María, Redondo, Javier Rivera, Hernández, Teresa González, González Polo, Francisco J., Almagro, Raúl Menor, Moreno, José M., Serret, Emilio Giner, Barroso, Carla Lannuzzelli, Méndez, Laura Cebrián, Navío, María Teresa, Carballido, Cristina Fernández, Pagán, Encarnación, del Castillo, Pablo Mesa, Naredo, Esperanza, Cruz, Ana, Turrión, Ana, Mateo, Isabel, Sánchez, Julio, Galindo, María, González, Javier García, Collantes, Eduardo, Ruíz, Desireé, Font, Pilar, Bonilla, Gema, Meseguer, Antonio López, Moreno, Manuel J., Martínez, M<ce:sup loc='post">a</ce:sup> José Moreno, Fernández, M<ce:sup loc='post">a</ce:sup> Dolores Beteta, Linares, Luis F., Morcillo, Mercedes, González Gómez, María L., Aramburu, José M., Rivera, Natalia A., Berrizbeitia, Olaia Fernández, García Vivar, María Luz, Riera, Manel, León, Yolanda María, Maymó, Joan, Amirall, Miriam, Escolano, Silvia Iniesta, Serrano, Silvia Sánchez, Lis Bona, María Pilar, Fiter, Jordi, Melón, Julia Fernández, Espadaler, Luis, Maiz, Olga, Belzunegui, Joaquín, Bañegil, Inmaculada, Díaz, César, Valls, Ramón, Castellví, Iván, Bonet, María, Ruzafa, Estefania Moreno, Alen, Jaime Calvo, Sandoval, Trinidad Pérez, Evrard, Eva Revuelta, Godo, Javier R., Espartero, Cruz Fernández, Navarro Blasco, Francisco J., González, José Antonio, Miranda-Filloy, José A., García-Gómez, Carmen, Martín-Martínez, Maria A., Castañeda, Santos, Sanchez-Alonso, Fernando, Uriarte-Ecenarro, Miren, González-Juanatey, Carlos, Romera-Baures, Montserrat, Santos-Rey, José, Pinto-Tasende, José Antonio, Quesada-Masachs, Estefanía, Tornero-Molina, Jesús, Martínez-González, Olga, Cobo-Ibáñez, Tatiana, Chamizo-Carmona, Eugenio, Manrique-Arija, Sara, Fábregas-Canales, Dolores, Díaz-González, Federico, Llorca, Javier, and González-Gay, Miguel A.

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results